Article Information
History
- June 14, 2021.
Article Versions
- Version 1 (April 14, 2021 - 20:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Agnes Norbury, PhD1,
- Sarah B. Rutter, MA1,
- Abigail B. Collins, BA1,
- Sara Costi, MD1,
- Manish K. Jha, MD1,
- Sarah R. Horn, MA1,
- Marin Kautz, MA1,
- Morgan Corniquel, MA1,
- Katherine A. Collins, PhD, LCSW1,2,
- Andrew M. Glasgow, MD3,
- Jess Brallier, MD3,
- Lisa M. Shin, PhD4,5,
- Dennis S. Charney, MD1,6,7,
- James W. Murrough, MD, PhD1,6 and
- Adriana Feder, MD1,*
- 1Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 2Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA
- 3Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 4Department of Psychology, Tufts University, Medford, MA, USA
- 5Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- 6Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 7Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- ↵*Corresponding author: Adriana Feder, MD, One Gustave L. Levy Place, Department of Psychiatry, Box 1230, New York, NY 10029, USA. E-mail: adriana.feder{at}mssm.edu
Posted June 14, 2021.
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos